Current through October 31, 2024
Section 312.145 - Guidance documents(a) FDA has made available guidance documents under § 10.115 of this chapter to help you to comply with certain requirements of this part.(b) The Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) maintain lists of guidance documents that apply to the centers' regulations. The lists are maintained on the Internet and are published annually in the FEDERAL REGISTER. A request for a copy of the CDER list should be directed to the Office of Training and Communications, Division of Drug Information, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002. A request for a copy of the CBER list should be directed to the Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Communication, Outreach and Development, 10903 New Hampshire Ave., Bldg. 71, Rm. 3103, Silver Spring, MD 20993-0002. 65 FR 56479 , Sept. 19, 2000, as amended at 74 FR 13113 , Mar. 26, 2009; 80 FR 18091 , Apr. 3, 2015